For Participants

Information for participants and those interested in participating

The Harvard Aging Brain Study (HABS) is an observational study that aims to find out whether the changes that a doctor sometimes sees on a brain scan are related to early memory changes that occur in older healthy adults.

For Researchers

The Harvard Aging Brain Study has published over 150 manuscripts contributing to the field of Alzheimer’s Disease research in major journals such as Nature, Alzheimer’s & Dementia, Neurology, and more. We invite researchers of diverse fields to expand and explore data used in this project, as both imaging and neuropsychological data are publicly available upon […]

Resources

Explore affiliated Alzheimer’s disease research centers, additional organizations, more studies, and useful resources.

Newsletters

Events

29
Feb

The McCourt Foundation – Educational Update 2020

Hear from Boston’s top doctors on progress in Alzheimer’s, ALS and MS

Boston Marriott Newton
2345 Commonwealth Avenue
Newton, MA, 02466

Join us for three informational sessions on Saturday, February 29, 2020, and hear from Boston’s leading doctors in the fields of Alzheimer’s, ALS and MS research. This annual program is aimed to elevate public awareness and support research designed to unlock the mysteries of these neurological diseases, as well as provide caregivers and patients with […]

HABS in the News

Widowhood Exacerbates Cognitive Decline in Alzheimer’s Disease

MedicalResearch.com Interview with Dr Nancy Donovan

MedicalResearch.com: What is the background for this study? Response: Prior research has shown that widowed older adults are more likely to experience cognitive decline than those who are married. However, there have been no prior studies of widowhood as a risk factor for cognitive decline due to Alzheimer’s disease, the most common cause of severe […]

The Search for an Earlier Alzheimer’s Diagnosis

The search for an antibody that could strike at the core of the disease

In a first-of-its kind trial, researchers are testing a drug they hope will stop Alzheimer’s disease in its tracks before damage begins. Neurologist Reisa Sperling is one of the country’s top medical minds and for her, Alzheimer’s is very personal. “My grandfather developed symptoms when I was applying to medical school, and it definitely influenced […]